How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
MAD Oral Device Market
- By Device Type: Custom-Fabricated MADs, Thermoplastic MADs, Boil-and-Bite MADs, Adjustable MADs, Non-Adjustable MADs
- By Material Type: Silicone, Thermoplastic Elastomer, Acrylic, Polyurethane, Ethylene Vinyl Acetate (EVA)
- By End-User: Dental Clinics, Sleep Disorder Centers, Hospitals, Home Care Users
- By Indication: Obstructive Sleep Apnea (OSA), Snoring, Bruxism
- By Distribution Channel: Dental Clinics and Practitioners, Online Retail, Specialty Medical Stores, Hospitals and Sleep Clinics
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Custom-Fabricated MADs leads By Device Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 13 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 13 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the MAD Oral Device Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 13 company profiles, forecast to 2033.
Segmentation covered
Device Type 5
Material Type 5
End-User 4
Indication 3
Distribution Channel 4
Companies profiled
ResMed Inc.
SomnoMed Limited
ProSomnus Sleep Technologies
Apnea Sciences Corporation
Philips Respironics
Panthera Dental
ORA Health
ZQuiet (Apnea Sciences)
TAP (Thornton Adjustable Positioner) by Airway Management Inc.
VitalSleep (SnoreRx)
SomniFix
SOVA Sleep
+1 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
13 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →ResMed Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →SomnoMed Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →ProSomnus Sleep Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Apnea Sciences Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Philips Respironics
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Panthera Dental
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →ORA Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →ZQuiet (Apnea Sciences)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →TAP (Thornton Adjustable Positioner) by Airway Management Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →VitalSleep (SnoreRx)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →SomniFix
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →SOVA Sleep
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →DentiTrac
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,797M by 2033 · 9.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Custom-Fabricated MADs55.9
- Thermoplastic MADs6.7
- Boil-and-Bite MADs12.8
- Adjustable MADs14.9
- Non-Adjustable MADs9.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$590.2M → $1,183M · 9.1%
Europe$411.3M → $797.8M · 8.6%
Asia Pacific$375.6M → $737.1M · 8.8%
Latin America$232.5M → $528.1M · 10.8%
Middle East and Africa$178.8M → $376.1M · 9.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.832026
9.832027
9.852028
9.862029
9.872030
9.882031
9.882032
9.912033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- ResMed Inc.12.3
- SomnoMed Limited23.1
- ProSomnus Sleep Technologies7.8
- Apnea Sciences Corporation11.1
- Philips Respironics6.4
- Panthera Dental11.3
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Device Type14.1%
Material Type19.3%
End-User30.1%
Indication16.9%
Distribution Channel19.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.7
- Europe22.0
- Asia Pacific20.3
- Latin America14.6
- Middle East and Africa10.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| ResMed Inc. | 86 | 89 | 92 | 93 | 88 | 93 | 90 |
| SomnoMed Limited | 74 | 84 | 87 | 70 | 79 | 93 | 81 |
| ProSomnus Sleep Technologies | 65 | 80 | 81 | 65 | 68 | 79 | 73 |
| Apnea Sciences Corporation | 59 | 64 | 72 | 60 | 81 | 73 | 68 |
| Philips Respironics | 55 | 57 | 68 | 57 | 65 | 62 | 61 |
| Panthera Dental | 52 | 48 | 61 | 62 | 53 | 55 | 55 |
| ORA Health | 63 | 48 | 55 | 60 | 44 | 50 | 53 |
| ZQuiet (Apnea Sciences) | 55 | 46 | 49 | 53 | 56 | 49 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- ResMed Inc.
- SomnoMed Limited
- ProSomnus Sleep Technologies
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| ResMed Inc. | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| SomnoMed Limited | ◐ | ✓ | ✓ | − | ◐ | ✓ |
| ProSomnus Sleep Technologies | ◐ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Apnea Sciences Corporation | ◐ | ◐ | ◐ | − | ✓ | ◐ |
| Philips Respironics | ◐ | ◐ | ◐ | − | ◐ | − |
| Panthera Dental | ◐ | ◐ | − | ◐ | − | − |
| ORA Health | − | − | − | ◐ | − | − |
| ZQuiet (Apnea Sciences) | − | − | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1ResMed Inc.90
2SomnoMed Limited81
3ProSomnus Sleep Technologies73
4Apnea Sciences Corporation68
5Philips Respironics61
6Panthera Dental55
7ORA Health53
8ZQuiet (Apnea Sciences)51
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
ResMed Inc.SomnoMed Limited
Challenger2
Strong scale, closing on the leaders.
ProSomnus Sleep TechnologiesApnea Sciences Corporation
Contender1
Focused players with pockets of strength.
Philips Respironics
Niche3
Specialists in a single segment or region.
Panthera DentalORA HealthZQuiet (Apnea Sciences)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Device Type in North America, then scale across MAD Oral Device Market — a $359M beachhead inside a $5.42B market.
Beachhead (SOM)$359Mobtainable near-term
Serviceable (SAM)$2.27Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Custom-Fabricated MADs
Best fit — highest urgency & budget in Device Type.
Economic buyer80 fit
Thermoplastic MADs
Strong fit — clear ROI and a fast path to value.
End user67 fit
Boil-and-Bite MADs
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Device Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel29%
Digital / self-serve18%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Device Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win MAD Oral Device Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified21%
Evaluation12%
Closed-won7%
$8.1KCAC
$36KLTV
4.4:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
MAD Oral Device Market is a resilient opportunity — $3.17B by 2033, compounding at 4.5%.
TAM · 2025$2.22Btoday
TAM · 2033$3.17Bforecast
CAGR4.5%2027–2033
Cumulative$24.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.17BTotal addressable market
SAM$1.29BServiceable available market
SOM$212MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.5% CAGR
Demand compounds through 2033, outpacing GDP across Device Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Device Type moving from early to mainstream — durable secular demand.
Consolidation upside
13+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.17BLarge & growingTAM by 2033 at 4.5% CAGR
$1.29BServiceable nowreachable with today’s model
$212MBeachhead winobtainable near-term share
13+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.47BBear2.9% CAGR
$3.17BBase4.5% CAGR
$4.05BBull6.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
MAD Oral Device Market — a $2.04B market by 2033. Plan: grow share from 8.7% to 13.6%.
Market size · 2033$2.04Btotal addressable
Market CAGR10.0%2027–2033
Target share13.6%from 8.7% today
Revenue ambition$277Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.7% | 13.6% | On track |
| Revenue | $161M | $277M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 33.4% | 44.9% | Behind |
| Customer retention | 86.5% | 93.2% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Device Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material Type capability
A defensible second engine — invest in Material Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Device Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $33M capacity & capability investment
- Greenlight bolt-on M&A in Material Type
- Authorise North America expansion plan
- Fund R&D program for Device Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeAhead
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the MAD Oral Device Market conversation — a $7.44B market you can size, segment and defend in minutes.
Market size · 2033$7.44Btotal opportunity
Growth4.4%CAGR to 2033
Addressable buyers1,251+accounts in scope
Typical ROI5.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Device Type
Goal Grow share in Device Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.7×return on cost, year one
< 3 mopayback period
$48K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
13+players profiled in this market
Coverage includes
ResMed Inc.SomnoMed LimitedProSomnus Sleep TechnologiesApnea Sciences CorporationPhilips RespironicsPanthera DentalORA HealthZQuiet (Apnea Sciences)+5 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your MAD Oral Device Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
MAD Oral Device Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Fingertip Pulse Oximetry Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportSeparation Systems for Commercial Biotechnology Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportMicroneedles for Trans amp Intradermal Drug Delivery Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportHolter Recorders Market
Market size, share, segmentation and regional forecast.
$353M market · 2025 base year
View reportAutoclaves for the CSSD Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportIshihara Test Book Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportLiver Biopsy Products Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportAluminum Medical Oxygen Cylinder Market
Market size, share, segmentation and regional forecast.
$696M market · 2025 base year
View reportPressure Mode Ventilators Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportHuman Endotracheal Tubes Market
Market size, share, segmentation and regional forecast.
$769M market · 2025 base year
View reportVolume Mode Ventilators Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportManual Surgical Tables Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.